Hormone-dependent Regulation of BRCA1 in Human Breast Cancer Cells

Cancer Research

Volumn 55, Issue 20, 1995, Pages 4561-4565

  Gudas, Jean M ^a   Nguyen, Hoang ^a   Li, Tao ^a   Cowan, Kenneth H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; MESSENGER RNA; ONCOPROTEIN; PROGESTERONE; PROGESTERONE RECEPTOR; STEROID HORMONE;

ARTICLE; BREAST CANCER; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENETIC SUSCEPTIBILITY; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BRCA1 PROTEIN; BREAST NEOPLASMS; CYCLINS; ESTRADIOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; IN VITRO; NEOPLASM PROTEINS; PROGESTERONE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0028875555     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Marshall, E. Search for a killer: focus shifts from fat to hormones. Science (Washington DC), 259: 618–621, 1993.
2. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Stano, A., Katcher, H., Kazuko, Y., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonon, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast, and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66–71, 1994.
3. Merajver, S. D., Pham, T. M., Caduff, R. F., Chen, M., Poy, E. L., Cooney, K. A., Weber, B. L., Collins, F. S., Johnston, C., and Frank, T. S. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat. Genet., 9: 439–443, 1995.
4. Nandi, S., Guzman, R. C., and Yang, J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA, 92: 3650–3657, 1995.
5. Freiss, G., Prebois, C., and Vignon, F. Control of breast cancer cell growth by steroids and growth factors: Interactions and mechanisms. Breast Cancer Res. Treat., 27: 57–68, 1993.
6. Clarke, R., Dickson, R. B., and Lippman, M. E. Hormonal aspects of breast cancer: growth factors, drugs and stromal interactions. Crit. Rev. Oncol. Hematol., 12: 1–23, 1992.
7. Gudas, J. M., Nguyen, H., Klein, R. C., Katayose, D., Seth, P., and Cowan, K. H. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res., 1: 71–80, 1995.
8. Masiakowski, P., Breathnach, R., Bloch, J., Gannon, F., Krust, A., and Cbambon, P. Goning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res., 10: 7895–7903, 1982.
9. Gudas, J. M., Klein, R. C., Oka, M., and Cowan, K. H. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Clin. Cancer Res., 1: 235–243, 1995.
10. Laborda, J. 36B4 cDNA as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res., 19: 3998, 1991.
11. Musgrove, E. A., HamUton, J. A., Lee, C. S. L., Sweeney, K. J. E., Watts, C. K. W., and Sutherland, R. L. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T47-D human breast cancer cell cycle progression. Mol. Cell. Biol., 13: 3577–3587, 1993.
12. Kalkhoven, E., Kwakkenbos-Isbrucker, L., deLaat, S. W., van der Saag, P. T., and van der Burg, B. Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol. Cell. Endocrinol., 102: 45–52, 1994.
13. Brown, A. M. C., Jeltsch, J.-M., Roberts, M., and Chambon, P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. USA, 81: 6344–6348, 1984.
14. Nunez, A.-M., Berry, M., Imler, J.-L., and Chambon, P. The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. EMBO J., 8: 823–829, 1989.
15. Sherr, C. J. G1 phase progression: cycling on cue. Cell, 79: 551–555, 1994.
16. Hunter, T., and Pines, J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell, 79: 573–582, 1994.
17. Hentze, M. W. Translational regulation: versatile mechanisms for metabolic and developmental control. Curr. Opin. Cell Biol., 7. 393–398, 1995.